Dr. Carolina Salcedo
Pharmacology Leader | Scientist | Strategic Advisor
Doctor in Pharmacology with 35+ years of experience in clinical and preclinical drug development, driving projects from discovery to Phase 3 and market. Proven expertise in leading international teams and securing biotech success through science and strategy.
Impact & Achievements
35+
Years of Experience
20+
Research Projects
4
Marketed Molecules
11
Clinical Trials
Key Molecules & Programs
Contributions across therapeutic areas, including marketed molecules and novel drug development.
- Cetraxal® — Ear drops
- Eberconazole (Ebernet®)
- Ebastine — Evastin, Kestine, Ebastel, Aleva, Ebatrol®
- Almotriptan — Axert, Almotrex, Amignul, Almogran®
- SNF472 — First-in-class vascular calcification inhibitor (Phase 3)
Teaching & Academic Contributions
Engaged in postgraduate teaching and doctoral supervision, shaping the next generation of scientists.
- 2022–2023 — Universidad Francisco de Vitoria
- 2023–2025 — Institut Quimic de Sarria
- PhD Supervision: Development of new indications for SNF472 (Author: Marc Blasco)
